10-Q: Acme United Corp Q1 2026 Earnings Show Revenue Growth, Profit Dip

Acme United Corporation reported a 14% increase in net sales for the first quarter of 2026, driven by acquisitions and organic growth, though net income decreased compared to the prior year.

Summary

• Acme United Corporation's net sales for the first quarter ended March 31, 2026, increased by 14% to $52.3 million, up from $45.9 million in the same period of 2025.
• Excluding the impact of the My Medic acquisition, comparable sales grew by 6%.
• Net income for the quarter was $0.985 million, a decrease from $1.653 million in the first quarter of 2025.
• Basic earnings per share were $0.26, down from $0.44 in the prior year.
• The company acquired the assets of My Medic for $18.6 million, which contributed $3.4 million in revenue during the quarter.
• Inventories increased to $63.386 million from $59.852 million.
• Long-term debt increased significantly to $33.030 million from $11.853 million, primarily due to increased borrowings under the revolving credit facility.
• The company was in compliance with its loan covenants as of March 31, 2026.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a negative sentiment score due to the significant decrease in net income and operating income, despite revenue growth, driven by increased costs and acquisition expenses.

Positives

• Consolidated net sales increased by 14% to $52.3 million for the first quarter of 2026 compared to $45.9 million in the prior year.
• Comparable sales (excluding the My Medic acquisition) increased by 6%.
• Net sales in the U.S. increased by 12%.
• Net sales in Canada increased by 16% in USD and 11% in local currency.
• European net sales increased by 32% in USD and 19% in local currency.
• Gross profit margin improved to 39.7% from 39.0%.
• Working capital increased by approximately $9.2 million.
• The current ratio improved to 4.57 from 4.21.
• The company was in compliance with its loan covenants.
• The company expects the impact of tariffs to lessen over the balance of 2026.

Negatives

• Net income decreased to $0.985 million from $1.653 million in the prior year's first quarter.
• Operating income decreased to $1.746 million from $2.426 million.
• Selling, general and administrative (SG&A) expenses increased by $3.548 million, primarily due to the My Medic acquisition and higher personnel costs.
• Tariff expenses impacted the first quarter due to selling inventory subject to high rates imposed in 2025.
• Long-term debt to equity ratio increased significantly to 36.3% from 18.1%.

Risks

• Volatility in global economic conditions impacting suppliers and customers.
• International trade policies, tariffs, and geopolitical tensions, including wars in Iran and Ukraine, potentially impacting demand, costs, and supply chains.
• Continuing adverse impact of inflation on product costs, transportation, and interest rates.
• Potential disruptions in supply chains due to pandemics, natural disasters, or labor shortages.
• Rising labor costs, including wages and benefits.
• Changes in customer needs and consumer spending habits.
• Currency fluctuations.
• The company's ability to effectively manage inventory in a rapidly changing business environment.
• Impact of competition and technological changes, including the growth of online marketing and sales.
• The company's ability to manage growth effectively and integrate acquisitions.
• Potential adverse effects from geopolitical instability in the Middle East on global shipping routes and energy markets.
• The company is purchasing approximately $10 million of inventory to mitigate potential shortages or price increases due to the war in Iran or other regional conflicts.
• Significant portion of products sourced from China are subject to potential U.S. tariffs and retaliatory measures.

Future Outlook

The company expects the impact of tariffs to gradually lessen over the balance of 2026 as it begins to sell inventory subject to lower tariffs. The company is also purchasing approximately $10 million of inventory for delivery in the second and third quarters of 2026 to mitigate potential shortages or price increases due to regional conflicts. Management believes that cash generated from operations and available credit facilities will be sufficient to finance operations over the next twelve months.

Management Comments

• Consolidated net sales for the three months ended March 31, 2026 were $52,301,000 compared to $45,958,000 in the same period in 2025, an increase of 14%. Excluding the incremental sales resulting from the acquisition of the assets of My Medic on January 15, 2026, comparable sales increased 6%.
• The increase in net sales for the three months ended March 31, 2026 was primarily due to increased sales of first aid and medical products and additional sales resulting from the acquisition of the assets of My Medic.
• The increase in SG&A expenses was primarily due to the acquisition of the assets of My Medic as well as higher personnel related expenses.
• The higher tariff expenses during the first quarter of 2026 resulted from the Company selling inventory that had been subject to high tariff rates imposed in 2025.
• We expect that the impact of tariffs on the Company will gradually lessen over the balance of 2026 as the Company begins to sell inventory subject to lower tariffs set in November 2025 and February 2026.
• In addition, we have commenced purchasing a total of approximately $10 million of inventory for delivery in the second and third quarters of 2026 to mitigate the potential shortages or price increases as a result of the war in Iran or other regional conflicts.

Industry Context

StockSavvy.ai notes that Acme United Corporation's Q1 2026 results reflect a common trend of revenue growth driven by acquisitions, a strategy frequently employed in the consumer goods and industrial products sectors to expand market share and product offerings. However, the decline in net income highlights the challenges many companies face with rising costs, including inflation, supply chain disruptions, and the impact of tariffs, which are prevalent concerns across global manufacturing and distribution industries.

Comparison to Industry Standards

• The reported 14% year-over-year revenue growth for Q1 2026 is robust, particularly for a company in the industrial and consumer products sector. For comparison, companies like Stanley Black & Decker (SWK) in the tools and storage segment have seen more modest growth in recent quarters, often in the low single digits, impacted by macroeconomic headwinds.
• The gross profit margin of 39.7% is competitive within the diversified industrial products space. For instance, Newell Brands (NWL), which has a diverse portfolio including consumer and commercial products, has reported gross margins in a similar range, though often subject to fluctuations based on product mix and input costs.
• The increase in SG&A expenses as a percentage of sales (36.4% vs. 33.7%) is a concern. This trend, if not managed, can erode profitability. Competitors often focus on optimizing SG&A through operational efficiencies and technology adoption to maintain margins, a challenge Acme United Corporation will need to address.
• The significant increase in long-term debt to equity ratio (36.3% from 18.1%) indicates a shift in capital structure, likely to fund acquisitions. While common in growth-oriented strategies, this increases financial risk. Industry peers often maintain leverage ratios within a certain range to ensure financial flexibility, with many aiming for ratios below 50% to maintain investment-grade credit profiles, though this varies significantly by industry sub-segment and company strategy.

Legal Proceedings

• There are no pending material legal proceedings to which the Company is a party, or, to the actual knowledge of the Company, contemplated by any governmental authority.

Stakeholder Impact

• Shareholders: Potential for reduced returns due to lower net income, but also potential for long-term growth from acquisitions. Increased debt levels may raise concerns about financial risk.
• Employees: Increased SG&A expenses may include higher personnel-related costs, potentially indicating wage increases or hiring. The company's ability to manage growth and integrate acquisitions will impact job security and opportunities.
• Suppliers: Increased inventory purchases and ongoing supply chain diversification efforts may impact supplier relationships and demand.
• Creditors: Increased long-term debt requires careful monitoring of the company's ability to meet its financial obligations and maintain compliance with loan covenants.

Next Steps

• Continue to monitor and manage the impact of tariffs and geopolitical tensions on operations and supply chains.
• Integrate the My Medic acquisition effectively to realize synergies and manage associated costs.
• Manage inventory levels and optimize supply chain strategies.
• Focus on controlling SG&A expenses to improve operating margins.
• Monitor compliance with loan covenants.

Key Dates

Recommendation

While revenue growth is positive, the significant decline in net income and operating income, coupled with increased debt and ongoing cost pressures (tariffs, inflation, SG&A), warrants a cautious approach. The company's ability to successfully integrate acquisitions and navigate external economic challenges will be key. A 'hold' recommendation reflects the mixed signals of growth potential offset by profitability concerns.

Keywords

Acme United Corporation, Form 10-Q, Quarterly Report, First Quarter 2026, Net Sales, Net Income, Earnings Per Share, Acquisition, My Medic, Inventories, Long-term Debt, Tariffs, Supply Chain, Financial Statements